M Ventures
M Ventures
About
We drive innovation and back entrepreneurs through equity investments and hands on support in fields that could impact the vitality and sustainability of Merck KGaA, Darmstadt, Germanys current and future businesses. We are the strategic, corporate venture capital arm of Merck KGaA, Darmstadt, Germany. Our mandate is to invest in innovative technologies and products with the potential to significantly impact Merck KGaA, Darmstadt, Germanys core business areas.
Key facts
- Website
- m-ventures.com
- Type
- Corporate Venture Capital
- Headquarters
- Germany
- Funds raised
- $485M
- Portfolio companies
- 27
- Stages
- SeedSeries ASeries BSeries B2Series C
- Cheque size
- $5M to $255M
- Sector focus
- 3D3D ImagingCMOSADASElectronics
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 1 Apr 2026 | STORM Therapeutics | Series C | $51M |
| 8 Jan 2026 | Vizgen | Series E | $48M |
| 2 Jan 2025 | Litmus | Series B | $30M |
| 7 Aug 2024 | Anjuna Security | Series B2 | $25M |
| 29 Apr 2024 | xMEMS | Series A | $21M |
| 3 Apr 2024 | Nucleai | Series B | $14M |
| 18 Mar 2024 | Celestial AI | Series C | $255M |
| 26 Jul 2023 | NeoLogic | Seed | $8M |
| 30 Mar 2023 | PxE Holographic Imaging | Seed | $5M |
| 1 Dec 2021 | Organox | Undisclosed round | $25M |
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Write the first review
Frequently asked
What companies has M Ventures invested in?
M Ventures has invested in STORM Therapeutics, Vizgen, Litmus, Anjuna Security, xMEMS and 22 more.
SEC filings, insider activity, nonprofit links and pay benchmarks for M Ventures:
